Electromagnetic interference of GSM mobile phones with the implantable deep brain stimulator, ITREL-III
© Kainz et al; licensee BioMed Central Ltd. 2003
Received: 23 December 2002
Accepted: 7 May 2003
Published: 7 May 2003
The purpose was to investigate mobile phone interference with implantable deep brain stimulators by means of 10 different 900 Mega Hertz (MHz) and 10 different 1800 MHz GSM (Global System for Mobile Communications) mobile phones.
All tests were performed in vitro using a phantom especially developed for testing with deep brain stimulators. The phantom was filled with liquid phantom materials simulating brain and muscle tissue. All examinations were carried out inside an anechoic chamber on two implants of the same type of deep brain stimulator: ITREL-III from Medtronic Inc., USA.
Despite a maximum transmitted peak power of mobile phones of 1 Watt (W) at 1800 MHz and 2 W at 900 MHz respectively, no influence on the ITREL-III was found. Neither the shape of the pulse form changed nor did single pulses fail. Tests with increased transmitted power using CW signals and broadband dipoles have shown that inhibition of the ITREL-III occurs at frequency dependent power levels which are below the emissions of GSM mobile phones. The ITREL-III is essentially more sensitive at 1800 MHz than at 900 MHz. Particularly the frequency range around 1500 MHz shows a very low interference threshold.
These investigations do not indicate a direct risk for ITREL-III patients using the tested GSM phones. Based on the interference levels found with CW signals, which are below the mobile phone emissions, we recommend similar precautions as for patients with cardiac pacemakers: 1. The phone should be used at the ear at the opposite side of the implant and 2. The patient should avoid carrying the phone close to the implant.
Today, the use of mobile phones is widespread and the number of users is increasing rapidly. It is generally known that an electromagnetic field of adequate intensity and frequency may interfere with implanted devices. Mobile phones are regarded as a potential source of electromagnetic interference with pacemakers - and defibrillators [6, 19, 20]. An extensive review of the literature [21, 22] demonstrated that up to now no examinations on electromagnetic compatibility aspects of deep brain stimulators (DBS) and mobile phones have been published. The malfunctions (inhibition, switch to the safety modus, i.e. stimulation with a fixed rate, and stimulation with a false signal) reported with pacemakers - due to the use of mobile phones may lead to discomfort and in rare cases to menacing situations for the pacemaker patient. These malfunctions depend on various parameters: frequency, transmitting power, modulation principle of the mobile phone system, distance between mobile phone and pacemaker, implantation depth, operating mode of the pacemaker as well as the interference immunity of the pacemaker. For older pacemakers a safety distance of 6 inches (15 centimeters) is sufficient to avoid malfunctions, although some publications recommend less than 6 inches. The use of the mobile phone on the opposite side of the pacemaker's location reduces the probability of interference. Subsequently, pacemaker patients should not carry the mobile phone in the breast pocket close to the pacemaker or, if the pacemaker is located in the abdomen, not on a belt, when it is switched on. Defibrillators seem to be less sensitive than pacemakers regarding electromagnetic fields emitted by mobile phones. Generally, the same precautions (6 inches or 15 centimeter minimum distance) as in the case of pacemakers should be encouraged. If these precautions are adhered to the possibility of interference with defibrillators can be minimized.
The increasing use of neurostimulators and mobile phones, and the lack of information on possible disturbance of DBSs due to exposure from mobile phones motivated us to carry out this study. We studied the interference of the DBS ITREL-III from Medtronic Inc. (Minneapolis, MN, USA) with GSM mobile phones operating at 900 MHz and 1800 MHz and with broadband diploes in the frequency range from 500 MHZ up to 2400 MHz. Unlike pacemakers and defibrillators, DBSs have no sensing inputs and therefore they should be more robust regarding electromagnetic interference. However, stimulation leads could act as antenna, picking up radio frequency (RF) currents and leading them into the device. Feed through filters should be able to handle this problem. However, the manufacturer did not disclose information of the implant design, the electronic circuit design, whether feed though filters where used or not and which other electromagnetic compatibility precautions were taken.
Neurological pulse generators are used as DBSs in the treatment of Parkinson's disease or as spinal cord stimulators. This study deals only with the ITREL-III as a DBS. Located in the chest region under the skin, the DBS stimulates certain areas of the brain, namely the thalamus or subthalamus [23, 24]. Due to its superior programming possibilities, the ITREL-III and ITREL-II are the DBSs preferred by our center for neurosurgery. A programming device can telemetrically adjust the stimulation parameters such as frequency, amplitude, and pulse duration. Two critical locations of the phone in respect of interference that correspond to typical use scenarios can be found: The region around the ear due to the closeness of the mobile phone antenna to the leads of the DBS and the breast region due to the potential closeness of the mobile phone to the DBS.
DBS Parameter Settings
Phantom Material Composition
Liquid phantom material
Jelly phantom material
In order to determine the influence of the plastic phantom shell on the field distribution, the difference in the attenuation between two dipoles with and without phantom shell were measured. The network analyzer HP 8753D was used for measuring the attenuation. To ensure that the maximum attenuation was found, the dipoles were arranged in a way that the electromagnetic wave had to penetrate three synthetic material layers. The maximum attenuation was 1%. During the interference immunity tests only one material layer was situated between the emitting antenna and the phantom liquid. Therefore, an essential influence of the phantom shell can be excluded.
The interference tests were performed in two steps. First we exposed the ITREL-III to electromagnetic fields of mobile phones. In addition we wanted to find out at which transmitted power an influence on the ITREL-III might occur. Therefore, we used broadband dipoles powered by a RF amplifier for the second part of the experiments.
Tests of commercially available mobile phones
The electromagnetic compatibility behavior of the ITREL-III was examined while exposing the ITREL-III to the fields of 10 different types of GSM 900 MHz mobile phones and 10 different GSM 1800 MHz mobile phones. Every mobile phone was tested in three different positions next to the phantom, using 2 different electrode configurations and 8 different stimulation parameters, SeeFF Table 1. Altogether, 960 different test configurations were examined. The power control of the handsets was adjusted at 900 MHz and 1800 MHz using the GSM tester "CMD 55" from Rhode & Schwarz. The maximum radiated peak power was 2 W (+/- 2 dB) at 900 MHz and 1 W (+/- 2 dB) at 1800 MHz, respectively.
in a non-typical position in front of the skull directly over the loop or meander; shown in Figure 8.
To observe the function of the ITREL-III the output signal at the connection of the lead to the implant case was monitored via a shielded cable on an oscilloscope. Interference with the field of the mobile phone and the monitoring cable was prevented by routing the monitoring cable out of the phantom to the oscilloscope on the opposite side (back of the phantom) of the interference source.
A 1018 S
Ad hoc testing of electronic implants with special types of mobile phones only gives reliable results for the tested phones. To know the safety margin for possible interference it is necessary to perform tests with more general interference sources. Therefore broadband dipoles were used to find out which power levels, depending on the frequency would cause interference.
Susceptibility tests using broadband dipoles
Such a scenario corresponds to the situation when a patient carries a mobile phone in his jacket. At each examined frequency, the transmitting power of the dipole was increased until the implant showed an influence. This power level is defined as the interference level. Special diligence was taken to measure the radiated power (forward minus reflected power). Generally, RF transmitter frequency tests were performed in frequency steps of 5 MHz. The frequency increment was reduced to 1 MHz only in bands where low interference levels were observed.
To estimate the electric field (E field) inside the phantom at the position of the implant we modeled, at 900 MHz and 1800 MHz, a simplified test setup using the Finite Difference Time Domain (FDTD) method with a grid size of 3 mm. A half-wavelength dipole was placed directly on a 3 mm thick flat plastic layer. Behind the flat plastic layer we modeled the liquid phantom material with dielectric properties for "Muscle tissue" given in Table 3. The model with the resulting E field distribution at 1800 MHz is shown in the results section in Figure 11.
The observed interference level at 900 MHz was 1.24 W (CW) or 100 V/m inside the liquid at the location of the implant and 0.14 W (CW) or 30 V/m inside the liquid at the location of the implant at 1800 MHz. A variation of the stimulation parameters does not lead to any essential change of the threshold value. The extremely low interference level at 1500 MHz should be noted. In this frequency range a few milli-watts (3 – 10 V/m) were sufficient to inhibit the ITREL-III. Tests on other locations of the dipole relative to the phantom (near the ear, the loop or the meander) showed no influence up to a maximum available radiation power of 6 W. The uncertainty of the transmitting power measurement was less than ± 30%, and is basically composed of the uncertainty of the power measurement itself and the uncertainty of the direction coupler parameters.
Figure 11 shows the E field distribution for 1800 MHz at a transmit power of 0.14 W, which corresponds to the observed interference level at 1800 MHz. The magnitude of the E field at the location of the implant (dashed rectangle) is about 30 V/m. The calculation at 900 MHz shows an E field of about 100 V/m at the location of the implant for a transmit power of 1.24 W.
The examinations have shown that the exposure of the ITREL-III to electromagnetic fields of GSM 900 MHz and 1800 MHz mobile phones does not result in inhibition or changes in the shape of the stimulation pulses. The investigations performed with mobile phones did not indicate a direct risk for ITREL-III patients while using the tested mobile phones in positions corresponding to the intended use. Tests with increased transmitting power have shown that an inhibition of the ITREL-III is caused at frequency dependent power levels. An "On/Off" switching of the reed switch of the implant could not be observed. Both interference levels found with CW signals using broadband dipoles (1.24 W or 100 V/m at 900 MHz and 0.14 W or 30 V/m at 1800 MHz) are below the maximum nominal peak power of GSM mobile phones. The GSM specifications allow a +/- 2dB offset from the nominal output power of 2 W at 900 MHz or 1 W at 1800 MHz, respectively. Even the lower boundary of the GSM power specifications (1.25 W at 900 MHz and 0.63 W at 1800 MHz) are above the interference levels found with CW signals using broadband dipoles. The question of why we could not find interference with real GSM phones although the interference levels found with broadband dipoles are below the emissions of GSM specifications remains open. A possible explanation is that a mobile phone is covered with a plastic case with losses which absorb energy and therefore reduce the emitted fields. Our broadband dipoles were not covered with plastic. Furthermore the plastic case of the mobile phone prevents the antenna or other metallic parts from touching the phantom shell as with the broadband dipoles we used. Particularly low interference levels were observed in the frequency range around 1500 MHz. This frequency range is used by Japanese mobile phones. Further examinations including mobile phones operating in this frequency band are recommended. A major finding was the strong frequency dependent interference level. Due to lack of information about the implant, particularly details about the electronic circuit design, the reason for the strong frequency dependence of the interference level and the very low interference level around 1500 MHz could not be determined. Other types of neurological stimulators could also have a frequency dependent interference level but with interference levels below the emissions of mobile phones at other frequencies. Unfortunately such neurological stimulators (e.g. ITREL-II, Soletra, Kinetra) were not available to perform similar tests. The assumption that the implant with a low battery level would be more susceptible to electromagnetic fields proved to be wrong. Both tested implants showed the same interference level. Regarding mobile phone safety of neurological pulse generators Medtronic only has information about the "Activa System" (Medtronic Web Site, http://www.medtronic.com/neuro/et/fields.html: Most of the electrical devices that people are around in a normal day will not harm the Activa System. This includes household appliances, computers, office machines, cellular phones, and personal radios. Special circuits inside the neurostimulator protect it from extreme electrical stress). Until information is available about the mobile phone compatibility of other neurological implants, especially older models, and there is a clarification of the ITREL-III interference below the emissions of GSM mobile phones, we recommend the following precautions based on investigations with cardiac pacemakers: 1. To use the phone at the ear opposite the side of the implant and 2. To carry the cell phone on the opposite side of the implant when it is in use or in "stand-by" modus. Due to the fact we were not aware of any investigations on DBS and mobile phones using other technologies as Universal Mobile Telecommunications System (UMTS) we suggest that patients with DBS should take into account the safety recommendations given above.
- Altamura G, Toscano S, Gentilucci G, Ammirati F: Influence of digital and analogue cellular telephones on implanted pacemakers. Eur Heart 1997, 18: 1632–1641.View ArticleGoogle Scholar
- Barbaro V, Bartolini P, Donato A, Militello C: Electromagnetic interference of analog cellular telephones with pacemakers: In vitro and in vivo studies. Pace 1999, 22: 626–634.View ArticleGoogle Scholar
- Carillo RG, Williams DB, Traad EA, Schor JS: Electromagnetic filters impede adverse interference of pacemakers by digital cellular telephones [Abstract]. Journal of the American College of Cardiology 1996,27(6):15A. 10.1016/S0735-1097(96)80243-9Google Scholar
- Chen WH, Lau CP, Leung S-K, Sai-Wah Ho D: Interference of cellular phones with implanted permanent pacemakers. Clin Cardiol 1996, 19: 881–886.View ArticleGoogle Scholar
- Ellenbogen KA, Wood MA: Cellular telephones and pacemakers: Urgent call or wrong number? Journal of the American College of Cardiology 1996,27(6):1478–1479. 10.1016/0735-1097(96)00086-1View ArticleGoogle Scholar
- Hayes D, Carrillo R, Findlay G, Embrey M: State of the science: Pacemaker and defibrillator interference from wireless communication devices. Pace 1996, 19: 1419–1430.View ArticleGoogle Scholar
- Hayes D, Wang P, Reynolds D, Estes M: Interference with cardiac pacemakers by cellular telephones. The New England Journal of Medicine 1997,336(21):1473–1479. 10.1056/NEJM199705223362101View ArticleGoogle Scholar
- Irnich W, Batz L, Müller R, Tobisch R: Electromagnetic interference of pacemakers by mobile phones. Pace 1996, 19: 1431–1446.View ArticleGoogle Scholar
- Naegeli B, Osswald S, Deola M, Burkart F: Intermittent pacemaker dysfunction caused by digital mobile phones. Journal of the American College of Cardiology 1996,27(6):1471–1477. 10.1016/0735-1097(96)00031-9View ArticleGoogle Scholar
- Ruggera P, Witters D, Bassen H: In vitro testing of pacemakers for digital cellular phone electromagnetic interference. Biomedical Instrumentation & Technology 1997,31(4):358–371.Google Scholar
- Sparks P, Mond H, Joyner K, Wood M: The safety of digital mobile cellular telephones with minute ventilation rate adaptive pacemakers. Pace 1996, 19: 1451–455.View ArticleGoogle Scholar
- Tan K, Hinberg I: Laboratory investigation of wireless digital communication system interference with implantable cardiac pacemakers. WTR Symposium Washington DC 1996.Google Scholar
- Trigano A, Azoulay A, Rochdi M, Campillo A: Electromagnetic interference of external pacemakers by walkie-talkies and digital cellular phones: experimental study. Pace 1999, 22: 588–593.View ArticleGoogle Scholar
- Wilke A, Grimm W, Funk R, Maisch B: Influence of D-Net (European GSM-Standard) cellular phones on pacemaker function in 50 patients with permanent pacemakers. Pace 1996, 19: 1456–1458.View ArticleGoogle Scholar
- Nowak B, Rosocha S, Zellerhoff C, Liebrich A: Is there a risk for interaction between mobile phones and single lead VDD pacemakers? Pace 1996, 19: 1447–1450.View ArticleGoogle Scholar
- Ravindran A, Schlegel R, Grant H, Raman S: In vitro study of the interaction between wireless phones and cardiac pacemakers. WTR Symposium Washington DC 1996.Google Scholar
- Raychowdhury G, Biswas A, Mitra K, Dasbiswas A: Interference of pacemaker by mobile phones [Abstract]. Pace 1997,20(II):2337.Google Scholar
- Ruggera P, Ravindran A, Tan K, Hayes L: Evaluation of the potential for hand held wireless telephones to interfere with implanted cardiac pacemakers. Wireless Technology Research Scientific Symposium Washington DC 1996.Google Scholar
- Barbaro V, Bartolini P, Bellocci F, Donato A: Electromagnetic interference of digital and analog cellular telephones with implantable car-dioverter defibrillators: In vitro and in vivo studies. Pace 1999, 22: 626–634.View ArticleGoogle Scholar
- Bassen H, Moore H, Ruggera P: Cellular phone interference testing of implantable cardiac defibrillator, in-vitro. Circulation 1995, 92: I-738.Google Scholar
- Kainz W, Neubauer G: Electromagnetic compatibility (EMC) of electronic implants. Austrian Research Centers Seibersdorf Report, OEFZS–E-0004 1999.Google Scholar
- Kainz W, Neubauer G, Alesch F, Schmid G, Jahn O: Electromagnetic Compatibility of Electronic Implants – Review of the Literature. Wiener Klinische Wochenschrift 2001, 113: 23–24.Google Scholar
- Alesch F, Pinter MM, Helscher RJ, Fertl L, Benabid AL, Koos WT: Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir 1995,136(1–2):75–81.View ArticleGoogle Scholar
- Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL: Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995,345(8942):91–95. 10.1016/S0140-6736(95)90062-4View ArticleGoogle Scholar
- Gabriel S, Lau R, Gabriel C: The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz. Phys Med Biol 1996, 41: 2251–2269. 10.1088/0031-9155/41/11/002View ArticleGoogle Scholar
- Institute of Electrical and Electronics Engineers (IEEE) SCC34 Draft Standard: Recommended Practice for Determining the Peak Spatial-Average Specific Absorption Rate (SAR) in the Human Body Due to Wireless Communications Devices: Experimental Techniques. IEEE Std 1528–2002.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.